995. Safety and Efficacy of F/TAF and F/TDF for PrEP in DISCOVER Participants Taking F/TDF for PrEP at Baseline

BACKGROUND: DISCOVER is an ongoing trial comparing emtricitabine plus tenofovir alafenamide (F/TAF) or tenofovir disoproxil fumarate (F/TDF) for HIV pre-exposure prophylaxis (PrEP). DISCOVER included some participants already taking F/TDF for PrEP at baseline (BL) creating a unique opportunity to st...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Open Forum Infect Dis
Autores principales: Campbell, Thomas, Clarke, Amanda, Trottier, Benoit, Carter, Christoph C, Shao, Yongwu, Ebrahimi, Ramin, Das, Moupali, Brainard, Diana M, Gladstein, Jay
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7777480/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa439.1181
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares